WeVote

Bill

Bill

SB 685

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES

2025 Regular Session Introduced by Pete Appollonio and 5 co-sponsors

Rhode Island pharmacy bill SB 685 referred for further study; specific provisions unavailable for analysis without bill text.

04/01/2025 Committee recommended measure be held for further study
0
WeVote Research Nonpartisan
Bill Summary · SB 685

Legislative bill overview

SB 685 is a Rhode Island bill addressing pharmacy regulations and business practices, though specific provisions are not detailed in the available documentation. The bill was introduced in March 2025 and referred to the Senate Health and Human Services Committee, which recommended it be held for further study in April 2025.

Why is this important

Pharmacy legislation directly affects healthcare access, drug pricing, and service availability for Rhode Island residents. Changes to pharmacy regulations can influence insurance coverage, medication costs, and the ability of pharmacists to provide expanded clinical services.

Potential points of contention

  • Without access to the bill's actual text, the specific regulatory changes—whether they expand or restrict pharmacy services, affect reimbursement rates, or modify licensing requirements—cannot be identified
  • The Committee's recommendation to "hold for further study" suggests potential disagreement among stakeholders about the bill's approach or necessity
  • Pharmacy bills often generate tension between retail pharmacies, chain drugstores, pharmaceutical manufacturers, insurance companies, and consumer advocacy groups with competing interests

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.